ABSTRACT
The evident seasonality of influenza suggests a significant role for weather and climate as one of several determinants of viral respiratory disease (VRD), including social determinants which play a major role in shaping these phenomena. Based on the current mechanistic understanding of how VRDs are transmitted by small droplets, we identify an environmental variable, Air Drying Capacity (ADC), as an atmospheric state-variable with significant and direct relevance to the transmission of VRD. ADC dictates the evolution and fate of droplets under given temperature and humidity conditions. The definition of this variable is rooted in the Maxwell theory of droplet evolution via coupled heat and mass transfer between droplets and the surrounding environment. We present the climatology of ADC, and compare its observed distribution in space and time to the observed prevalence of influenza and COVID-19 from extensive global data sets. Globally, large ADC values appear to significantly constrain the observed transmission and spread of VRD, consistent with the significant coherency of the observed seasonal cycles of ADC and influenza. Our results introduce a new environmental determinant, rooted in the mechanism of VRD transmission, with potential implications for explaining seasonality of influenza, and for describing how environmental conditions may impact to some degree the evolution of similar VRDs, such as COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: Massachusetts Institute of Technology. No external funding was received for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
6-hourly temperature, dew point temperature and surface pressure data at 0.75 degree spatial resolution between 1979 and 2018 were obtained from the ERA-Interim reanalysis (available at http://apps.ecmwf.int/datasets/). Since ERA-Interim is only available up to 2019, we used 6-hourly ERA5T35 data (0.25 by 0.25 degree horizontal resolution) for the recent February-April 2020 period. Daily COVID-19 epidemiological data compiled by the Johns Hopkins University Center for Systems Science and Engineering is available at country-scale since 22 January 2020 at https://data.humdata.org/. The most up-to-date COVID data for each US state at a daily temporal resolution is taken from the COVID Tracking Project (https://covidtracking.com/data/). Population data for world countries and US states was downloaded from https://www.worldometers.info/world-population and https://www.wikipedia.org, respectively. Weekly laboratory confirmed influenza cases by country for the period October 15th, 1995 to August 31st, 2019 are retrieved from the World Health Organization's FluNet database, accessible at https://www.who.int/influenza/gisrs_laboratory/flunet/en/. The dataset consists in weekly totals of identified influenza A and B cases, along with the number of subjects tested.
http://apps.ecmwf.int/datasets/
